Access links:
CONTENT
Destacados
Molecular Epidemiology
Projects
- Actiu
CCR5 / CXCR4 co-receptor tropism prediction in chronically HIV-1-infected subjects with suppressed viremia using ultradeep sequencing of the V3 loop of gp160 in total and episomal PBMC-associated HIV-1 DNA
Financing entity: Pfizer Spain, S.A.
Participant entities:
Date: 01/01/2008
Research Supervisor(s): Roger Paredes
Also related to: Molecular Epidemiology
- Inactiu
Impact of mutations in the connection and RNAseH domains of the HIV-1 reverse transcriptase and virological response to NNRTI-based HAART in the EuroSIDA Cohort: the CONNECT Study
Financing entity: Boehringer-Ingelheim, Spain
Participant entities:
Date: 01/01/2008
Research Supervisor(s): Roger Paredes
Also related to: Molecular Epidemiology
- Actiu
Incorporación de la Pirosecuenciación a la Detección de Poblaciones Minoritarias de VIH-1 y Desarrollo de Nuevos Algoritmos de Predicción de Resistencia Genotípica en la Práctica Clínica
Financing entity: Ministerio de Industria.
Participant entities: Programa I+D+I del CDTI
Date: 01/01/2008
Research Supervisor(s): Roger Paredes
Also related to: Molecular Epidemiology
- Actiu
HIV-1 viral dynamics in subjects initiating raltegravir therapy
Financing entity: Merck Sharp & Dohme de España, S.A.
Participant entities:
Date: 01/01/2008
Research Supervisor(s): Roger Paredes
Also related to: Molecular Epidemiology
- Inactiu
Impact of Raltegravir Intensification on HIV-1 viral latency in Patients with Previous Complete Viral Suppression: a 48 week randomized, controlled, open-label, proof-of-concept pilot clinical trial
Financing entity: Merck & Co.
Participant entities: Fundació IrsiCaixa
Date: 01/08/2007
Also related to: Molecular EpidemiologyRetrovirology and Clinical Studies Group (GREC)
